BiotechTube

Eraxis (anidulafungin) + Diflucan (fluconazole) + Vfend (voriconazole)

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Candidiasis

Conditions

Candidiasis

Trial Timeline

Jul 1, 2007 → Jun 1, 2010

NCT ID
NCT00496197

About Eraxis (anidulafungin) + Diflucan (fluconazole) + Vfend (voriconazole)

Eraxis (anidulafungin) + Diflucan (fluconazole) + Vfend (voriconazole) is a approved stage product being developed by Pfizer for Candidiasis. The current trial status is completed. This product is registered under clinical trial identifier NCT00496197. Target conditions include Candidiasis.

What happened to similar drugs?

4 of 20 similar drugs in Candidiasis were approved

Approved (4) Terminated (4) Active (13)
✅Fluconazole + MicafunginAstellas PharmaApproved
✅Caspofungin + Normal SalineMerckApproved
✅VoriconazolePfizerApproved
✅Clotrimazole vaginal tablet + FluconazoleBayerApproved
🔄Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
🔄Micafungin + fluconazoleAstellas PharmaPhase 3
🔄Micafungin + CaspofunginAstellas PharmaPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00496197ApprovedCompleted

Competing Products

20 competing products in Candidiasis

See all competitors
ProductCompanyStageHype Score
MicafunginAstellas PharmaPhase 1
29
Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
40
Micafungin + fluconazoleAstellas PharmaPhase 3
40
Micafungin (Mycamine)Astellas PharmaPhase 1
29
Fluconazole + MicafunginAstellas PharmaApproved
35
Micafungin + CaspofunginAstellas PharmaPhase 3
40
Micafungin + FluconazoleAstellas PharmaPhase 3
40
MicafunginAstellas PharmaPhase 2
35
micafungin + caspofunginAstellas PharmaPhase 3
40
micafungin + amphotericin B deoxycholateAstellas PharmaPhase 3
32
FK463Astellas PharmaPhase 2
35
Micafungin + Liposomal Amphotericin BAstellas PharmaPhase 3
40
SHR8008 + FluconazoleJiangsu Hengrui MedicinePhase 3
36
SHR8008 capsule + Fluconazole capsuleJiangsu Hengrui MedicinePhase 3
36
L-743,872MerckPre-clinical
26
CaspofunginMerckPhase 2
35
L-743,872MerckPhase 2
27
Caspofungin + Amphotericin B DeoxycholateMerckPhase 2
27
Caspofungin acetate + PlaceboMerckPhase 2
27
Caspofungin + Normal SalineMerckApproved
43